Trials / Conditions / Stargardt Macular Degeneration
Stargardt Macular Degeneration
3 registered clinical trials studyying Stargardt Macular Degeneration — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Prelimina NCT06942572 | Splice Bio | Phase 1 / Phase 2 |
| Active Not Recruiting | Open-Label Extension: Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE) NCT04239625 | Alkeus Pharmaceuticals, Inc. | Phase 2 |
| Enrolling By Invitation | Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease NCT02402660 | Alkeus Pharmaceuticals, Inc. | Phase 2 |